e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
Asthma assessment and original therapeutic approaches
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased serum IL-17 does not predict future risk and impairment in asthma
I. Agache, C. Ciobanu, A. Balan, C. Agache, M. Anghel, R. Oprea (Brasov, Romania)
Source:
Annual Congress 2009 - Asthma assessment and original therapeutic approaches
Session:
Asthma assessment and original therapeutic approaches
Session type:
E-Communication Session
Number:
4556
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
I. Agache, C. Ciobanu, A. Balan, C. Agache, M. Anghel, R. Oprea (Brasov, Romania). Increased serum IL-17 does not predict future risk and impairment in asthma. Eur Respir J 2009; 34: Suppl. 53, 4556
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Increased serum IL-17 is an independent risk factor for severe asthma
Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity
Year: 2008
Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity
Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020
Year: 2021
Elevated circulating MMP-9 is associated with increased exacerbation risk in COPD: results from SPIROMICS and COPDGene
Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD?
Year: 2018
Increased CCL18 serum levels in patients with pulmonary fibrosis which reflect disease severity
Source: Eur Respir J 2005; 26: Suppl. 49, 21s
Year: 2005
Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
Characterisation of asthma subgroups associated with circulating YKL-40 levels
Source: Eur Respir J, 50 (4) 1700800; 10.1183/13993003.00800-2017
Year: 2017
Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016
Is serum leptin level a predictor for asthma?
Source: Eur Respir J 2005; 26: Suppl. 49, 681s
Year: 2005
Increased plasma fibrinogen could predict frequent exacerbations in asthma
Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases
Year: 2020
Serum levels of IL-6 in adult patients with moderate to severe asthma.
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017
Elevated serum IL-12 and IL-18 levels in patients with bronchial asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 424s
Year: 2002
Increased TNFα production in whole blood is associated with disease severity in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 497s
Year: 2002
The relationship between the serum YKL-40 level and severity of asthma
Source: Annual Congress 2012 - Asthma management
Year: 2012
The role of IL-18 level and genetic polymorphism in patients with bronchial asthma and its relation to disease severity
Source: Annual Congress 2012 - Gene-environment treatment and asthma
Year: 2012
The role of Hs-CRP in evaluating asthma severity and asthma control
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010
Comorbidities and elevated IL-6 associate with negative outcome in adult-onset asthma
Source: Eur Respir J 2016; 48: 1052-1062
Year: 2016
Elevated serum IL-8: a biomarker indicating exacerbation-prone COPD
Source: International Congress 2017 – COPD biomarkers
Year: 2017
Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009
Serum IL-17 and IL-18 levels in asthma-COPD overlap syndrome patients
Source: International Congress 2015 – Promising novel findings in translational pulmonary research
Year: 2015
Serum KL-6 as a biomarker to assess risk of worse outcome in patients with SARS-CoV2 infection
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept